Sinovac Biotech Ltd (SVA) — Long-term Investment Intensity
Sinovac Biotech Ltd (SVA) has a Long-term Investment Intensity of 5.3% as of June 2024. Long-term investments of $681.35 Million represent 5.3% of total assets of $12.90 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Sinovac Biotech Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sinovac Biotech Ltd Long-term Investment Intensity (2021–2023)
This chart shows how Sinovac Biotech Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2021 to 2023. As of June 2024, the intensity stands at 5.3%, reflecting long-term investments of $681.35 Million against total assets of $12.90 Billion USD. Explore SVA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Sinovac Biotech Ltd (2021–2023)
The table below presents the year-by-year Long-term Investment Intensity for Sinovac Biotech Ltd from 2021 to 2023, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Sinovac Biotech Ltd market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 5.0% | $684.28 Million | $13.66 Billion | ▲ +0.3 pp |
| 2022 | 4.7% | $661.44 Million | $14.11 Billion | ▲ +0.8 pp |
| 2021 | 3.9% | $655.84 Million | $16.75 Billion | — |